Career Center
AES Connect
Donate
supervisor_account
check_circle
Get Involved
search
search
Search
menu
Menu
Home
Abstracts
Abstracts
[
11
]C-Diprenorphine (DPN) PET in Malformations of Cortical Development (MCD).
Feb 5, 2021, 20:55 PM
Creative Innovation after Temporal Lobectomy
Feb 5, 2021, 20:55 PM
Autism and Epilepsy- Cause, Result, Comorbidity or Coincidence?
Feb 5, 2021, 20:55 PM
Evolution of Temporal Lobe Epilepsy Observed with 11.1 Tesla MRI In Vivo
Feb 5, 2021, 20:55 PM
Associated Viruses in Benign Convulsions with Mild Gastroenteritis
Feb 5, 2021, 20:55 PM
Bioequivalence of Rufinamide Oral Suspension Formulation and the Marketed Tablet
Feb 5, 2021, 20:55 PM
NEURODEVELOPMENTAL AND EPILEPSY OUTCOMES IN A NORTH AMERICAN COHORT OF INFANTILE SPASMS PATIENTS
Feb 5, 2021, 20:55 PM
SOCIOECONOMIC DEPRIVATION IS AN INDEPENDENT RISK FACTOR FOR BEHAVIOURAL PROBLEMS IN CHILDREN WITH EPILEPSY.
Feb 5, 2021, 20:55 PM
LONG-LASTING CHANGES IN INTRINSIC PROPERTIES OF SURVIVING MOSSY CELLS AFTER HEAD INJURY
Feb 5, 2021, 20:55 PM
The effects of antiepileptic drugs on serum lipids, homocysteine, and C-reactive protein
Feb 5, 2021, 20:55 PM
ASSOCIATION AMONG TEMPORAL LOBE EPILEPSY WITH MESIAL TEMPORAL SCLEROSIS AND PSYCHOSIS
Feb 5, 2021, 20:55 PM
Meta-analysis of Epilepsy Surgery in Patients Above 50 Years of Age
Feb 5, 2021, 20:55 PM
PUBLIC AWARENESS OF, ATTITUDES TOWARD AND UNDERSTANDING OF EPILEPSY IN CHICAGO’S HISPANIC-AMERICAN COMMUNITY
Feb 5, 2021, 20:55 PM
Isolated Subthalamic Nucleus Spikes: Are They Epileptogenic?
Feb 5, 2021, 20:55 PM
Resting State Connectivity Changes of Normal Brain Structures due to AED Modulation: An SEEG Study
Feb 5, 2021, 20:55 PM
ZONISAMIDE DISPOSITION AND DOSAGE ADJUSTMENT WHEN GIVEN WITH PHENYTOIN
Feb 5, 2021, 20:55 PM
Surveillance of clinical use of lacosamide in Norway: Patient and population aspects
Feb 5, 2021, 20:55 PM
Antiepileptic Drug Treatment Lowers Coenzyme Q10 Levels in Children.
Feb 5, 2021, 20:55 PM
UTILITY OF SPECT SCANS IN NONEPILEPTIC SEIZURES
Feb 5, 2021, 20:55 PM
NO DOSE ADJUSTMENTS OF OXCARBAZEPINE REQUIRED IN MILD OR MODERATE HEPATICALLY IMPAIRED PATIENTS
Feb 5, 2021, 20:55 PM
«
1181
1182
1183
1184
1185
1186
1187
1188
1189
1190
»